According to Ho et al., patients with non-small cell lung carcinoma (NSCLC) who have high expression of TREM1 in their tumor-associated macrophages are more likely to experience cancer recurrence and poor survival may have additional clinical implications [32]. This evidence concerns the gene TREM1 and non-small cell lung carcinoma.